Bristol-Myers Breast Cancer Drug Won US FDA Approval!

BMSCWashington: Bristol-Myers Squibb Co.’s made new chemotherapy drug called Ixempra for women with ad

Deployment of army in FATA challenged in Pakistan Supreme Court

Islamabad, Oct 18 : The deployment of the armed forces in Pakistan’s tribal areas bordering Afghanistan has been challenged before the Supreme Court here.

Ministry Refuses To Accept AIIMS Report

Anbumani RamadossNew Delhi: Now, another issue has emerged between AIIMS and the h

Britain To Spend 45 Billion Pounds On Obesity By 2050

Overweight kids show early signs of heart disease

Washington, Oct 18 : Children who are obese or at the risk of obesity show early signs of heart diseases, a new study by researchers at the Washington University School of Medicine has revealed.

Mani Shankar Aiyar Hospitalized!

Mani Shanker AiyarChennai: Mani Shanker Aiyar, the Union Minister for Panchay

Pages

News in Focus

Ujjivan Small Finance Bank Share Price Target at Rs 55: ICICI Securities

ICICI Securities has reiterated a BUY rating on Ujjivan Small Finance Bank, forecasting a compelling 25% upside from current levels.

GIWA Blockchain’s Bold Entry into Ethereum Layer 2: Can It Redefine Web3 Simplicity and Speed?

A new player has stepped firmly into the Ethereum Layer 2 arena, and its ambitions extend beyond incremental improvements.

3M India Share Price Target at Rs 35,610: ICICI Securities

ICICI Securities Limited maintains its bullish stance on 3M India with a BUY recommendation and an ambitious target price of Rs 35,610 from the current market price of Rs 30,835, r

Navin Fluorine Share Price Target at Rs 5,075: Deven Choksey

Deven Choksey Research has issued an "ACCUMULATE" recommendation for Navin Fluorine International Ltd, setting a target price of Rs 5,075 from the current market price of Rs 4,663, indicating an 8.

Triveni Turbine Share Price Target at Rs 700: Sharekhan Research

Mirae Asset Sharekhan has reaffirmed its BUY recommendation for Triveni Turbine Ltd (TTL) with a robust price target of Rs. 700, representing significant upside potential from current levels.

SRF Limited Share Price Target at Rs 3,540: ShareKhan Research

Mirae Asset Sharekhan has reinforced its BUY recommendation on SRF Limited with an unchanged price target of Rs.